iTeos Therapeutics has agreed to be acquired by privately held Concentra Biosciences in a deal initially worth roughly $385 million. iTeos on Monday said Concentra will pay nearly $10.05 a share in ...

Located in KEZAD and operated by Rafed, a subsidiary of PureHealth, the hub was developed in collaboration with the DoH, Abu ...

Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate of Abu Dhabi, has announced the operational launch of ...